Protection against omicron (B. 1.1. 529) BA. 2 reinfection conferred by primary omicron BA. 1 or pre-omicron SARS-CoV-2 infection among health-care workers with …

…, N Brousseau, R Gilca, J Fafard… - The Lancet Infectious …, 2023 - thelancet.com
Background There is a paucity of data on vaccine-induced or infection-induced (hybrid or
natural) immunity against omicron (B.1.1.529) subvariant BA.2, particularly in comparing the …

Estimated protection of prior SARS-CoV-2 infection against reinfection with the Omicron variant among messenger RNA–vaccinated and nonvaccinated individuals in …

…, R Gilca, M Ouakki, S Barkati, J Fafard… - JAMA network …, 2022 - jamanetwork.com
Importance The Omicron variant is phylogenetically and antigenically distinct from earlier
SARS-CoV-2 variants and the original vaccine strain. Protection conferred by prior SARS-CoV-…

Monkeypox in Montréal: epidemiology, phylogenomics, and public health response to a large North American outbreak

…, G Cadieux, H Charest, J Fafard… - Annals of Internal …, 2023 - acpjournals.org
Background: Monkeypox, a viral zoonotic disease, is causing a global outbreak outside of
endemic areas. Objective: To characterize the outbreak of monkeypox in Montréal, the first …

[PDF][PDF] A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses

…, L Gokool, C Morrisseau, P Arlotto, R Bazin, J Fafard… - Cell reports, 2022 - cell.com
Due to the recrudescence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infections worldwide, mainly caused by the Omicron variant of concern (VOC) and its sub-…

Protection against Omicron re-infection conferred by prior heterologous SARS-CoV-2 infection, with and without mRNA vaccination

…, N Brousseau, R Gilca, M Ouakki, S Barkati, J Fafard… - medRxiv, 2022 - medrxiv.org
Importance Omicron is phylogenetically- and antigenically-distinct from earlier SARS-CoV-2
variants and the original vaccine strain. Protection conferred by prior SARS-CoV-2 infection …

Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case …

…, C Sauvageau, N Brousseau, J Fafard… - The Lancet Healthy …, 2023 - thelancet.com
Background Older adults (aged ≥60 years) were prioritised for COVID-19 booster vaccination
due to severe outcome risk, but the risk for this group is also affected by previous SARS-…

Natural spring water gargle and direct RT-PCR for the diagnosis of COVID-19 (COVID-SPRING study)

…, F Coutlée, PJ Dufresne, J Longtin, J Fafard… - Journal of Clinical …, 2021 - Elsevier
Background Nasopharyngeal swab has long been considered the specimen of choice for the
diagnosis of respiratory viral infections, including SARS-CoV-2 infection, but it suffers from …

Single-dose effectiveness of mpox vaccine in Quebec, Canada: test-negative design with and without adjustment for self-reported exposure risk

…, G Cadieux, G Bergeron, J Fafard… - Clinical Infectious …, 2024 - academic.oup.com
Introduction During the 2022 mpox outbreak, the province of Quebec, Canada, prioritized
first doses for pre-exposure vaccination of people at high mpox risk, delaying second doses …

Natural spring water gargle samples as an alternative to nasopharyngeal swabs for SARS‐CoV‐2 detection using a laboratory‐developed test

…, J Bestman‐Smith, J Fafard… - Journal of Medical …, 2022 - Wiley Online Library
The objective of this study was to validate the use of spring water gargle (SWG) as an alternative
to oral and nasopharyngeal swab (ONPS) for SARS‐CoV‐2 detection with a laboratory‐…

Comparison of SARS‐CoV‐2 detection with the Cobas® 6800/8800 system on gargle samples using two sample processing methods with combined oropharyngeal …

…, C Lavallée, M Roger, J Fafard… - Journal of medical …, 2021 - Wiley Online Library
Background Gargle samples have been proposed as a noninvasive method for detection of
SARS‐CoV‐2 RNA. The clinical performance of gargle specimens diluted in Cobas® PCR …